CVS Caremark Corporation (NYSE:CVS) said net revenues increased 4.6% to $32.8 billion, with Pharmacy Services up 5.2% and Retail Pharmacy up 5.6%. Adjusted EPS increased 15.8% to $1.12, beating estimates, while GAAP diluted EPS increased 16.9% to $1.05. Excluding a $0.17 per share loss on early extinguishment of debt in the fourth quarter of 2012, adjusted EPS decreased 1.9%.
The company confirmed full year adjusted EPS guidance of $4.36 to $4.50, GAAP diluted EPS from continuing operations of $4.09 to $4.23. Additionally CVS raised first quarter adjusted EPS guidance of $1.03 to $1.06 and GAAP diluted EPS of $0.97 to $1.00.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.